I. | Information paper(s) issued since the last meeting(4:30 pm - 4:35 pm) | ||
LC Paper No. CB(2)326/18-19(01) (issued on 28 November 2018) | - | 2017-2018 Annual Report of the Health and Medical Research Fund provided by the Administration
| |
LC Paper No. CB(2)373/18-19(01) (Chinese version only) (issued on 4 December 2018) | - | Letter dated 29 November 2018 from Dr Hon Helena WONG requesting the Panel to discuss the management and testing of pharmaceutical products
| |
LC Paper No. CB(2)374/18-19(01) (Chinese version only) (issued on 4 December 2018) | - | Letter dated 29 November 2018 from Dr Hon Fernando CHEUNG requesting the Panel to discuss the safeguarding of the rights of patients with rare diseases through legislation
| |
LC Paper No. CB(2)375/18-19(01) (Chinese version only) (issued on 4 December 2018) | - | Submission dated 27 November 2018 from Self Help Group for the Brain Damaged proposing the Panel to discuss the measures for stroke prevention
| |
LC Paper No. CB(2)455/18-19(01) (Chinese version only) (issued on 14 December 2018) | - | Letter dated 13 December 2018 from Dr Hon KWOK Ka-ki requesting the Panel to discuss issues relating to the definition of proprietary Chinese medicines under the Chinese Medicine Ordinance (Cap. 549) and the registration of these products
| |
II. | Items for discussion at the next meeting(4:35 pm - 4:40 pm) | ||
LC Paper No. CB(2)423/18-19(01) (issued on 14 December 2018) | - | List of outstanding items for discussion
| |
LC Paper No. CB(2)423/18-19(02) (issued on 14 December 2018) | - | List of follow-up actions
| |
III. | Development of Chinese medicine(4:40 pm - 5:35 pm) | ||
LC Paper No. CB(2)423/18-19(03) (Chinese version issued on 11 December 2018; English version issued on 13 December 2018) | - | Paper provided by the Administration
| |
LC Paper No. CB(2)423/18-19(04) (issued on 14 December 2018) | - | Background brief on development of Chinese medicine hospital and provision of subsidized Chinese medicine services prepared by the Legislative Council Secretariat
| |
LC Paper No. CB(2)423/18-19(05) (issued on 14 December 2018) | - | Background brief on Chinese Medicine Development Fund prepared by the Legislative Council Secretariat
| |
Other relevant paper
| |||
LC Paper No. CB(2)473/18-19(01)
(Chinese version only) (attached) | - | Submission dated 17 December 2018 from Hong Kong Chinese Medicine Pharmacists Association
| |
IV. | Collaboration-referral mechanism between Department of Health and Hospital Authority in respect of dermatological services provided by Department of Health(5:35 pm - 6:25 pm) | ||
LC Paper No. CB(2)423/18-19(06) (issued on 11 December 2018) | - | Paper provided by the Administration
| |
LC Paper No. CB(2)423/18-19(07) (issued on 13 December 2018) | - | Information note prepared by the Legislative Council Secretariat
| |
Other relevant paper
| |||
LC Paper No. CB(2)341/18-19(01) (Chinese version only) (issued on 28 November 2018) | - | Submission dated 23 November 2018 from Hong Kong Psoriasis Patients Association proposing the Panel to discuss the provision of dermatology service in the public healthcare system and treatment for psoriasis
| |
V. | Any other business(6:25 pm - 6:30 pm) |